The creation of CBTI is an important strategic initiative under the so-called "two-wheel driving strategy" set by Asymchem Pharmaceutical Group. CBTI is one of the eight technology centers currently in operation within the Group. Inspired by the success achieved by Asymchem’s technology-driven strategy, CBTI pursues the innovative technology and holistic solutions to empower the scientific breakthrough and satisfying delivery of client’s projects.
CBTI’s Responsibilities: To nurture AsymBio’s capabilities in scientific innovation, process R&D, platform solutions and supply chain optimization for the development and manufacturing of biological molecules (e.g. antibodies, recombinant biotherapeutics, and bioconjugates, etc.) and advanced therapy medicinal products.
CBTI’s Objectives: To build up our capabilities in cutting-edge technologies for the future growth of AsymBio, to provide comprehensive and high-quality solutions to the clients around the globe, and to better empower and accelerate the R&D and transformation process of innovative drugs.
The CBTI team is formed by a group of high-caliber scientists from the industry. Currently, the center owns a number of cutting-edge technologies and has made breakthroughs in several complex and challenging key projects.